Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Opioid Growth Factor
100%
Naltrexone
64%
Enkephalin
53%
Opioid Growth Factor Receptor (OGFr)
50%
Opioid Receptors
35%
Opioid Antagonist
26%
Cell Proliferation
24%
DNA Synthesis
22%
Endogenous Opioids
21%
Methadone
16%
Opioids
14%
Experimental Autoimmune Encephalomyelitis
11%
Receptor Blockade
11%
Ocular Surface
11%
Low-dose Naltrexone
10%
Multiple Sclerosis
10%
Diabetic Rats
10%
Endogenous Opioid System
10%
Naloxone
10%
Head-and-neck
9%
Squamous Cell Carcinoma of Head
9%
Re-epithelialization
8%
Labeling Index
8%
Human Pancreatic Cancer
8%
Opioid Peptides
8%
Developing Rat
8%
Lactation
8%
Tissue Culture
8%
Cerebellum
8%
Tumor
8%
Cornea
7%
Diabetes
7%
Brain Development
7%
Neuroblastoma
7%
Nude Mice
7%
Proenkephalin
7%
Growth Factors
7%
Young Rats
7%
Corneal Epithelium
7%
Adult Rats
6%
β-endorphin
6%
Epithelium
6%
Morphine
6%
Diabetic
5%
Receptor-mediated
5%
Angiogenesis
5%
Binding Site
5%
Immunoreactivity
5%
Corneal Sensitivity
5%
Topical Application
5%
Neuroscience
Growth Factor
73%
Receptor
66%
Naltrexone
42%
Enkephalin
41%
Growth Factor Receptor
30%
Endorphin
29%
Narcotic Antagonist
21%
Cell Proliferation
18%
Methadone
15%
DNA Synthesis
13%
Neuroblastoma
12%
Cerebellum
12%
Experimental Autoimmune Encephalomyelitis
11%
Opioid Peptide
10%
Epithelium
9%
Diabetes Mellitus
8%
Ontogeny
7%
Peptide
7%
Naloxone
7%
Multiple Sclerosis
7%
Messenger RNA
6%
Cornea
6%
Morphine
6%
Preproenkephalin
5%
Binding Site
5%
Behavior (Neuroscience)
5%
Brain Development
5%